Panel Discussion: Delving into FDA vs EU Perspective on Retinal Imaging Endpoints to Demonstrate Functional Vision
Time: 9:30 am
day: Conference Day Two
Details:
- Detailing how the FDA and EU approach the adoption of new retinal imaging technologies
- Discussing the divergent regulatory standards of each organization
- Highlighting the growing focus on functionality and quality of life improvements for patients
